Microbix Biosystems Inc.
MBXBF · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $25 | $17 | $19 | $19 |
| % Growth | 53.8% | -13.4% | 2.6% | – |
| Cost of Goods Sold | $10 | $9 | $8 | $8 |
| Gross Profit | $15 | $7 | $11 | $11 |
| % Margin | 60.6% | 45.3% | 58.3% | 59.4% |
| R&D Expenses | $2 | $2 | $2 | $1 |
| G&A Expenses | $9 | $7 | $5 | $4 |
| SG&A Expenses | $9 | $8 | $7 | $5 |
| Sales & Mktg Exp. | $0 | $1 | $2 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | $10 | $9 | $6 |
| Operating Income | $4 | -$3 | $3 | $5 |
| % Margin | 15.4% | -16.6% | 14.1% | 26% |
| Other Income/Exp. Net | -$0 | $3 | -$1 | -$2 |
| Pre-Tax Income | $4 | -$0 | $2 | $3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $4 | -$0 | $2 | $2 |
| % Margin | 13.9% | -0.2% | 9.4% | 8.8% |
| EPS | 0.026 | -0 | 0.013 | 0.014 |
| % Growth | 8,700% | -102.3% | -7% | – |
| EPS Diluted | 0.026 | -0 | 0.013 | 0.012 |
| Weighted Avg Shares Out | 137 | 138 | 135 | 115 |
| Weighted Avg Shares Out Dil | 137 | 138 | 142 | 142 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $2 |
| Depreciation & Amortization | $2 | $1 | $1 | $1 |
| EBITDA | $6 | $2 | $3 | $6 |
| % Margin | 24.4% | 11.9% | 17.4% | 30.4% |